BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/26/2024 1:28:46 PM | Browse: 48 | Download: 90
 |
Received |
|
2023-11-15 16:52 |
|
Peer-Review Started |
|
2023-11-15 16:53 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-12-15 02:29 |
|
Revised |
|
2023-12-18 19:34 |
|
Second Decision |
|
2024-01-25 03:04 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2024-01-25 04:46 |
|
Articles in Press |
|
2024-01-25 04:46 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-02-20 15:54 |
|
Publish the Manuscript Online |
|
2024-02-26 13:28 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Autoimmune pancreatitis: Cornerstones and future perspectives
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Camilla Gallo, Giulia Dispinzieri, Nicola Zucchini, Pietro Invernizzi and Sara Massironi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Sara Massironi, MD, PhD, Chief Physician, Doctor, Medical Assistant, Research Scientist, Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, Fondazione IRCCS San Gerardo dei Tintori; University of Milano-Bicocca, No. 33 Via Pergolesi, Monza 20900, Italy. sara.massironi@libero.it |
| Key Words |
Autoimmunity; Pancreatitis; Autoimmune pancreatitis; Immunoglobulin G4; Steroids; Relapse |
| Core Tip |
Autoimmune pancreatitis (AIP) is rare and often misdiagnosed. The lymphoplasmacytic sclerosing form, type 1 AIP (AIP-1), represents the pancreatic manifestation of immunoglobulin G4-related disease, while the idiopathic ductal centric form, type 2 AIP (AIP-2), is often associated with inflammatory bowel disease. AIP-1 presents with obstructive jaundice or abnormalities in exocrine and endocrine pancreatic function; AIP-2 usually shows abdominal pain and acute pancreatitis. The atypical mass-forming abnormality of the pancreas implies the need to histologically distinguish AIP form pancreatic ductal adenocarcinoma. Steroids are the first-line therapy for both AIP-1 and AIP-2, rituximab is a good alternative for AIP-1. Given the high relapse rate, long-term maintenance therapy is recommended. Scientific efforts are focusing on target therapies. |
| Publish Date |
2024-02-26 13:28 |
| Citation |
Gallo C, Dispinzieri G, Zucchini N, Invernizzi P, Massironi S. Autoimmune pancreatitis: Cornerstones and future perspectives. World J Gastroenterol 2024; 30(8): 817-832 |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i8/817.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i8.817 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
